1-4 of 4
Feng Lin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Perioperative ctDNA-Based Molecular Residual Disease Detection for Non–Small Cell Lung Cancer: A Prospective Multicenter Cohort Study (LUNGCA-1)

Liang Xia, Jiandong Mei, Ran Kang, Senyi Deng, Yaohui Chen, Ying Yang, Gang Feng, Yulan Deng, Fanyi Gan, Yidan Lin, Qiang Pu, Lin Ma, Feng Lin, Yong Yuan, Yang Hu, Chenglin Guo, Hu Liao, Chengwu Liu, Yunke Zhu, Wenping Wang, Zheng Liu, Yuyang Xu, Kaidi Li, Chuan Li, Qingyun Li, Ji He, Weizhi Chen, Xiaolong Zhang, Yingli Kou, Yun Wang, Zhu Wu, Guowei Che, Longqi Chen, Lunxu Liu
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (15): 3308–3317.
https://doi.org/10.1158/1078-0432.CCR-21-3044
Published: 02 August 2022
View article titled, Perioperative ctDNA-Based Molecular Residual Disease Detection for Non–Small Cell Lung Cancer: A Prospective Multicenter Cohort Study (LUNGCA-1)
Open the PDF for Perioperative ctDNA-Based Molecular Residual Disease Detection for Non–Small Cell Lung Cancer: A Prospective Multicenter Cohort Study (LUNGCA-1) in another window
Includes: Supplementary data
Journal Articles

D-2-Hydroxyglutarate Is an Intercellular Mediator in IDH-Mutant Gliomas Inhibiting Complement and T Cells

Lingjun Zhang, Mia D. Sorensen, Bjarne W. Kristensen, Guido Reifenberger, Thomas M. McIntyre, Feng Lin
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (21): 5381–5391.
https://doi.org/10.1158/1078-0432.CCR-17-3855
Published: 01 November 2018
View article titled, D-2-Hydroxyglutarate Is an Intercellular Mediator in IDH-Mutant Gliomas Inhibiting Complement and T Cells
Open the PDF for D-2-Hydroxyglutarate Is an Intercellular Mediator in IDH-Mutant Gliomas Inhibiting Complement and T Cells in another window
Includes: Supplementary data
Journal Articles

Thirty-Gene Pharmacogenomic Test Correlates with Residual Cancer Burden after Preoperative Chemotherapy for Breast Cancer

Florentia Peintinger, Keith Anderson, Chafika Mazouni, Henry M. Kuerer, Christos Hatzis, Feng Lin, Gabriel N. Hortobagyi, W. Fraser Symmans, Lajos Pusztai
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (14): 4078–4082.
https://doi.org/10.1158/1078-0432.CCR-06-2600
Published: 18 July 2007
View article titled, Thirty-Gene Pharmacogenomic Test Correlates with Residual Cancer Burden after Preoperative Chemotherapy for Breast Cancer
Open the PDF for Thirty-Gene Pharmacogenomic Test Correlates with Residual Cancer Burden after Preoperative Chemotherapy for Breast Cancer in another window
Journal Articles

High Frequency of Epidermal Growth Factor Receptor Mutations with Complex Patterns in Non–Small Cell Lung Cancers Related to Gefitinib Responsiveness in Taiwan

Shiu-Feng Huang, Hui-Ping Liu, Ling-Hui Li, Yuan-Chieh Ku, Yu-Ning Fu, Hsien-Yu Tsai, Ya-Ting Chen, Yung-Feng Lin, Wen-Cheng Chang, Han-Pin Kuo, Yi-Cheng Wu, Yi-Rong Chen, Shih-Feng Tsai
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (24): 8195–8203.
https://doi.org/10.1158/1078-0432.CCR-04-1245
Published: 28 December 2004
View article titled, High Frequency of Epidermal Growth Factor Receptor Mutations with Complex Patterns in Non–Small Cell Lung Cancers Related to Gefitinib Responsiveness in Taiwan
Open the PDF for High Frequency of Epidermal Growth Factor Receptor Mutations with Complex Patterns in Non–Small Cell Lung Cancers Related to Gefitinib Responsiveness in Taiwan in another window